Company · CIK 1612042
Ascendis Pharma A/S
| CIK | 1612042 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | G7 |
| Listed | ASND (Nasdaq) |
| First annual or quarterly report | 2015-03-26 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-216882 | 2017-03-22 | 2018-02-23 | 7 | |
| 333-211511 | 2016-05-20 | 2016-10-19 | 4 | |
| 333-209336 | 2016-02-02 | 2016-02-17 | 2 | |
| 333-201050 | 2014-12-18 | 2015-01-28 | 5 |
Filings
29| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2024-09-20 | 424B5Shelf takedown | 333-282196 | 0001193125-24-222869 |
| 2024-09-18 | 424B5Shelf takedown | 333-282196 | 0001193125-24-221479 |
| 2021-09-02 | 424B5Shelf takedown | 333-256571 | 0001193125-21-264544 |
| 2021-08-31 | 424B5Shelf takedown | 333-256571 | 0001193125-21-262153 |
| 2020-07-09 | 424B5Shelf takedown | 333-225284 | 0001193125-20-190428 |
| 2020-07-06 | 424B5Shelf takedown | 333-225284 | 0001193125-20-187810 |
| 2019-03-06 | 424B5Shelf takedown | 333-225284 | 0001193125-19-065750 |
| 2019-03-04 | 424B5Shelf takedown | 333-225284 | 0001193125-19-062499 |
| 2019-02-08 | 424B5Shelf takedown | 333-225284 | 0001193125-19-032444 |
| 2018-02-23 | 424B5Shelf takedown | 333-216882 | 0001193125-18-054361 |
| 2018-02-20 | 424B5Shelf takedown | 333-216882 | 0001193125-18-050544 |
| 2017-09-28 | 424B5Shelf takedown | 333-216882 | 0001193125-17-296163 |
| 2017-09-26 | 424B5Shelf takedown | 333-216882 | 0001193125-17-294564 |
| 2017-05-23 | 424B5Shelf takedown | 333-216882 | 0001193125-17-179711 |
| 2017-04-05 | EFFECTDeclared effective | 333-216882 | 9999999995-17-000739 |
| 2017-03-22 | F-3Shelf registered | 333-216882 | 0001193125-17-092124 |
| 2016-10-19 | 424B5Shelf takedown | 333-211511 | 0001193125-16-741740 |
| 2016-10-18 | 424B5Shelf takedown | 333-211511 | 0001193125-16-740766 |
| 2016-06-02 | EFFECTDeclared effective | 333-211511 | 9999999995-16-004815 |
| 2016-05-20 | F-3Shelf registered | 333-211511 | 0001193125-16-597726 |
| 2016-02-17 | EFFECTDeclared effective | 333-209336 | 9999999995-16-003793 |
| 2016-02-02 | F-3Shelf registered | 333-209336 | 0001193125-16-447629 |
| 2015-01-28 | 424B4Final prospectus | 333-201050 | 0001193125-15-023765 |
| 2015-01-27 | EFFECTDeclared effective | 333-201695 | 9999999995-15-000216 |
| 2015-01-27 | EFFECTDeclared effective | 333-201050 | 9999999995-15-000212 |
| 2015-01-26 | F-1/AAmendment | 333-201050 | 0001193125-15-019424 |
| 2015-01-16 | F-1/AAmendment | 333-201050 | 0001193125-15-012416 |
| 2014-12-18 | F-1Registration filed | 333-201050 | 0001193125-14-446974 |
| 2014-08-01 | DRSDraft made public | 377-00717 | 0000950123-14-007655 |